Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197


Effector memory T cells, early metastasis, and survival in colorectal cancer.

Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J.

N Engl J Med. 2005 Dec 22;353(25):2654-66.


In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.

Pagès F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, Lagorce C, Wind P, Marliot F, Bruneval P, Zatloukal K, Trajanoski Z, Berger A, Fridman WH, Galon J.

J Clin Oncol. 2009 Dec 10;27(35):5944-51. doi: 10.1200/JCO.2008.19.6147. Epub 2009 Oct 26.


Coordination of intratumoral immune reaction and human colorectal cancer recurrence.

Camus M, Tosolini M, Mlecnik B, Pagès F, Kirilovsky A, Berger A, Costes A, Bindea G, Charoentong P, Bruneval P, Trajanoski Z, Fridman WH, Galon J.

Cancer Res. 2009 Mar 15;69(6):2685-93. doi: 10.1158/0008-5472.CAN-08-2654. Epub 2009 Mar 3.


Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.

Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B.

J Clin Oncol. 2009 Jan 10;27(2):186-92. doi: 10.1200/JCO.2008.18.7229. Epub 2008 Dec 8.


Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer.

Suzuki H, Chikazawa N, Tasaka T, Wada J, Yamasaki A, Kitaura Y, Sozaki M, Tanaka M, Onishi H, Morisaki T, Katano M.

Cancer Immunol Immunother. 2010 May;59(5):653-61. doi: 10.1007/s00262-009-0781-9. Epub 2009 Nov 12.


Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.

Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pagès F.

Science. 2006 Sep 29;313(5795):1960-4.


Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.

Zlobec I, Baker K, Minoo P, Jass JR, Terracciano L, Lugli A.

Clin Cancer Res. 2008 Jan 1;14(1):143-8. doi: 10.1158/1078-0432.CCR-07-1380.


Low expression of Granzyme B in colorectal cancer is associated with signs of early metastastic invasion.

Salama P, Phillips M, Platell C, Iacopetta B.

Histopathology. 2011 Aug;59(2):207-15. doi: 10.1111/j.1365-2559.2011.03915.x.


Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.

Anichini A, Molla A, Vegetti C, Bersani I, Zappasodi R, Arienti F, Ravagnani F, Maurichi A, Patuzzo R, Santinami M, Pircher H, Di Nicola M, Mortarini R.

Cancer Res. 2010 Nov 1;70(21):8378-87. doi: 10.1158/0008-5472.CAN-10-2028. Epub 2010 Sep 21.


Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.

Zlobec I, Minoo P, Baumhoer D, Baker K, Terracciano L, Jass JR, Lugli A.

Cancer. 2008 Feb 1;112(3):495-502.


Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G.

N Engl J Med. 2003 Jan 16;348(3):203-13.


Ex-vivo analysis of CD8+ T cells infiltrating colorectal tumors identifies a major effector-memory subset with low perforin content.

Ye SW, Wang Y, Valmori D, Ayyoub M, Han Y, Xu XL, Zhao AL, Qu L, Gnjatic S, Ritter G, Old LJ, Gu J.

J Clin Immunol. 2006 Sep;26(5):447-56. Epub 2006 Sep 12.


Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.

de Jong RA, Leffers N, Boezen HM, ten Hoor KA, van der Zee AG, Hollema H, Nijman HW.

Gynecol Oncol. 2009 Jul;114(1):105-10. doi: 10.1016/j.ygyno.2009.03.022. Epub 2009 May 2.


CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival.

Koelzer VH, Lugli A, Dawson H, Hädrich M, Berger MD, Borner M, Mallaev M, Galván JA, Amsler J, Schnüriger B, Zlobec I, Inderbitzin D.

J Transl Med. 2014 Mar 29;12:81. doi: 10.1186/1479-5876-12-81.


Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.

Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, Nasti G, Barletta E, Facchini G, Daniele B, Di Blasi A, Napolitano M, Ieranò C, Calemma R, Leonardi E, Albino V, De Angelis V, Falanga M, Boccia V, Capuozzo M, Parisi V, Botti G, Castello G, Vincenzo Iaffaioli R, Scala S.

Clin Cancer Res. 2006 May 1;12(9):2795-803.


A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.

Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.


Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.


Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis.

Chang CC, Shih JY, Jeng YM, Su JL, Lin BZ, Chen ST, Chau YP, Yang PC, Kuo ML.

J Natl Cancer Inst. 2004 Mar 3;96(5):364-75.


Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence.

Nakamori S, Watanabe H, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, Kabuto T, Raz A.

Cancer. 1994 Oct 1;74(7):1855-62.


[Effect of tumor burden on differentiation of T lymphocytes in the peripheral blood of patients with colorectal cancer].

Cui M, Wang S, Ye YJ, Cui ZR, Ke Y.

Zhonghua Yi Xue Za Zhi. 2007 Jan 2;87(1):16-9. Chinese.

Items per page

Supplemental Content

Support Center